Arm Inc. said it's expanding its presence in Austin, which is already its largest site in the U.S.
The downtown Cincinnati-based firm, publicly traded since 2022, is making a major pivot with its latest M&A attempt.
Chief executive Brian Niccol explains why he thinks AI will help the coffee giant regain its buzz.
Spring training starts Tuesday as pitchers and catchers return to the field just 102 days after the World Series. Players are ...
(NASDAQ:AIMD) (NASDAQ:AIMDW) ("Ainos" or the "Company"), a SmellTech platform company digitizing scent as a native data language for artificial intelligence, today announced a technology partnership ...
Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, today announced the ...
Near.AI introduces a secure, private, Rust-based version of OpenClaw called IronClaw, Olas prediction agents unleashed Polymarket. AI Eye.
Dismissing the social network for bots would be a mistake - its very weirdness underscores real concerns and highlights why ...
In an era where data is the backbone of insight and strategy, businesses are constantly looking for innovative ways to ...
Slop’ pull requests from LLMs are deluging maintainers, and you can generate small utility functions on your own in seconds. The open source world is grappling with AI.
There are parallels to be found between Waltz and his scary movies. While Dr. Frankenstein is analytical and ambitious, ...
Opinion
8don MSNOpinion
The UK's new cancer strategy is bold and ambitious - it can't afford to be anything else
A National Cancer Plan for England "that will revolutionise the way we treat cancer". It is a bold and ambitious claim to make, but this strategy cannot afford to be anything else.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results